PMC:7556165 / 59761-60316
Annnotations
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T171 | 379-387 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T350 | 176-186 | Species | denotes | SARS-CoV-2 | NCBItxid:2697049 |
T351 | 176-180 | Species | denotes | SARS | NCBItxid:694009 |
T352 | 200-205 | Species | denotes | human | NCBItxid:9606 |
T353 | 334-339 | Species | denotes | human | NCBItxid:9606 |
T354 | 486-494 | Species | denotes | COVID-19 | NCBItxid:2697049 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T361 | 0-555 | Sentence | denotes | In the meanwhile, partial but important information might be obtained by circumscribed experimental and clinical investigations focused some on crucial issues, namely: fate of SARS-CoV-2 infection in human cells manipulated in order to modify ACE2 density; correlation of ACE2 density (in different cell types) and clinical course in human patients; potential role of additional proteins interacting with ACE2, such as the membrane transporter SIT1, which appears to be associated with COVID-19 prognosis and is also affected by anti-hypertensive therapy. |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
1645 | 243-247 | Gene | denotes | ACE2 | Gene:59272 |
1646 | 272-276 | Gene | denotes | ACE2 | Gene:59272 |
1647 | 405-409 | Gene | denotes | ACE2 | Gene:59272 |
1648 | 444-448 | Gene | denotes | SIT1 | Gene:27240 |
1649 | 200-205 | Species | denotes | human | Tax:9606 |
1650 | 334-339 | Species | denotes | human | Tax:9606 |
1651 | 340-348 | Species | denotes | patients | Tax:9606 |
1652 | 423-431 | Gene | denotes | membrane | Gene:43740571 |
1653 | 176-196 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
1654 | 486-494 | Disease | denotes | COVID-19 | MESH:C000657245 |
1655 | 534-546 | Disease | denotes | hypertensive | MESH:D006973 |
LitCovid-sample-UniProt
Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
---|---|---|---|---|---|
T5769 | 243-247 | Protein | denotes | ACE2 | https://www.uniprot.org/uniprot/Q9UFZ6 |
T5770 | 272-276 | Protein | denotes | ACE2 | https://www.uniprot.org/uniprot/Q9UFZ6 |
T5771 | 405-409 | Protein | denotes | ACE2 | https://www.uniprot.org/uniprot/Q9UFZ6 |
LitCovid-sample-PD-IDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T228 | 187-196 | http://purl.obolibrary.org/obo/IDO_0000586 | denotes | infection |
T229 | 206-211 | http://purl.obolibrary.org/obo/CL_0000000 | denotes | cells |
T230 | 299-303 | http://purl.obolibrary.org/obo/CL_0000000 | denotes | cell |
LitCovid-sample-PD-FMA
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T402 | 206-211 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T403 | 299-303 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T404 | 379-387 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T344 | 176-186 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T345 | 176-180 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T346 | 187-196 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T347 | 486-494 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-sample-PD-GO-BP-0
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T106 | 423-443 | http://purl.obolibrary.org/obo/GO_0055085 | denotes | membrane transporter |
LitCovid-sample-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T108 | 423-443 | http://purl.obolibrary.org/obo/GO_0055085 | denotes | membrane transporter |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1645 | 243-247 | Gene | denotes | ACE2 | Gene:59272 |
1646 | 272-276 | Gene | denotes | ACE2 | Gene:59272 |
1647 | 405-409 | Gene | denotes | ACE2 | Gene:59272 |
1648 | 444-448 | Gene | denotes | SIT1 | Gene:27240 |
1649 | 200-205 | Species | denotes | human | Tax:9606 |
1650 | 334-339 | Species | denotes | human | Tax:9606 |
1651 | 340-348 | Species | denotes | patients | Tax:9606 |
1652 | 423-431 | Gene | denotes | membrane | Gene:43740571 |
1653 | 176-196 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
1654 | 486-494 | Disease | denotes | COVID-19 | MESH:C000657245 |
1655 | 534-546 | Disease | denotes | hypertensive | MESH:D006973 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T361 | 0-555 | Sentence | denotes | In the meanwhile, partial but important information might be obtained by circumscribed experimental and clinical investigations focused some on crucial issues, namely: fate of SARS-CoV-2 infection in human cells manipulated in order to modify ACE2 density; correlation of ACE2 density (in different cell types) and clinical course in human patients; potential role of additional proteins interacting with ACE2, such as the membrane transporter SIT1, which appears to be associated with COVID-19 prognosis and is also affected by anti-hypertensive therapy. |